5-ALA fluorescence-assisted surgery in pediatric brain tumors: Report of three cases and review of the literature

References

• Bloch O, Han SJ, Cha S, et al. Impact of extent of resection for recurrent glioblastoma on overall survival: clinical article. J Neurosurg 2012;117:1032–8.
   PubMed Web of Science ®Google Scholar
• Kuhnt D, Becker A, Ganslandt O, et al. Correlation of the extent of tumor volume resection and patient survival in surgery of glioblastoma multiforme with high-field intraoperative MRI guidance. Neuro Oncol 2011;13:1339–48.
   PubMed Web of Science ®Google Scholar
• Orringer D, Lau D, Khatri S, et al. Extent of resection in patients with glioblastoma: limiting factors, perception of resectability, and effect on survival. J Neurosurg 2012;117:851–9.
   PubMed Web of Science ®Google Scholar
• Stummer W, Reulen HJ, Meinel T, et al.; ALA-Glioma Study Group. Extent of resection and survival in glioblastoma multiforme: identification of and adjustment for bias. Neurosurgery 2008; 62:564–76.
   PubMed Web of Science ®Google Scholar
• Stummer W, van den Bent MJ, Westphal M. Cytoreductive surgery of glioblastoma as the key to successful adjuvant therapies: new arguments in an old discussion. Acta Neurochir (Wien) 2011;153:1211–8.
   PubMed Web of Science ®Google Scholar
• Lacroix M, Abi-Said D, Fourney DR, et al. A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg 2001;95:190–8.
   PubMed Web of Science ®Google Scholar
• Mineo JF, Bordron A, Baroncini M, et al. Prognosis factors of survival time in patients with glioblastoma multiforme: a multivariate analysis of 340 patients. Acta Neurochir (Wien) 2007;149:245–53.
   PubMed Web of Science ®Google Scholar
• Sanai N, Berger MS. Glioma extent of resection and its impact on patient outcome. Neurosurgery 2008;62:753–66.
   PubMed Web of Science ®Google Scholar
• Sanai N, Polley MY, McDermott MW, Parsa AT, Berger MS. An extent of resection threshold for newly diagnosed glioblastomas. J Neurosurg 2011;115:3–8.
   PubMed Web of Science ®Google Scholar
• Vuorinen V, Hinkka S, Färkkilä M, Jääskeläinen J. Debulking or biopsy of malignant glioma in elderly people—a randomized study. ActaNeurochir (Wien) 2003;145:5–10.
   PubMed Web of Science ®Google Scholar
• Ewelt C, Floeth FW, Felsberg J, et al. Finding the anaplastic focus in diffuse gliomas: the value of Gd-DTPA enhanced MRI, FET-PET, and intraoperative, ALA-derived tissue fluorescence. Clin Neurol Neurosurg 2011;113:541–7.
   PubMed Web of Science ®Google Scholar
• Nabavi A, Thurm H, Zountsas B, et al.; 5-ALA Recurrent Glioma Study Group. Five-aminolevulinic acid for fluorescence-guided resection of recurrent malignant gliomas: a phase ii study. Neurosurgery 2009;65:1070–7.
   PubMed Web of Science ®Google Scholar
• Stummer W, Pichlmeier U, Meinel T, et al., ALA-Glioma Study Group. Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol 2006;7:392–401.
   PubMed Web of Science ®Google Scholar
• Stummer W, Nestler U, Stockhammer F, et al. Favorable outcome in the elderly cohort treated by concomitant temozolomide radiochemotherapy in a multicentric phase II safety study of 5-ALA. J Neurooncol 2011;103:361–70.
   PubMed Web of Science ®Google Scholar
• Stummer W, Tonn JC, Mehdorn HM, et al.; ALA-Glioma Study Group. Counterbalancing risks and gains from extended resections in malignant gliomasurgery: a supplemental analysis from the randomized 5-aminolevulinic acid glioma resection study. Clinical article. J Neurosurg 2011;114:613–23.
   PubMed Web of Science ®Google Scholar
• Coluccia D, Fandino J, Fujioka M, et al. Intraoperative 5-aminolevulinic-acid-induced fluorescence in meningiomas. Acta Neurochir (Wien) 2010;152:1711–9.
   PubMed Web of Science ®Google Scholar
• Kamp MA, Grosser P, Felsberg J, et al. 5-aminolevulinic acid (5-ALA)-induced fluorescence in intracerebral metastases: a retrospective study. Acta Neurochir (Wien) 2012;154:223–8.
   PubMed Web of Science ®Google Scholar
• Kamp MA, Santacroce A, Zella S, et al. Is it a glioblastoma? In dubio pro 5-ALA! Acta Neurochir (Wien) 2012;154:1269–73.
   PubMed Web of Science ®Google Scholar
• Porensky P, Chiocca EA. Use of 5-aminolevulinic acid for visualization of low-grade gliomas. J Neurosurg 2011;115:737–9.
   PubMed Web of Science ®Google Scholar
• Preuß M, Renner C, Krupp W, et al. The use of 5-aminolevulinic acid fluorescence guidance in resection of pediatric brain tumors. Childs Nerv Syst 2013;29:1263–7.
   PubMed Web of Science ®Google Scholar
• Ruge JR, Liu J. Use of 5-aminolevulinic acid for visualization and resection of a benign pediatric brain tumor. J Neurosurg Pediatr 2009;4:484–6.
   PubMed Web of Science ®Google Scholar
• Stummer W, Stocker S, Wagner S, et al. Intraoperative detection of malignant gliomas by 5-aminolevulinic acid-induced porphyrin fluorescence. Neurosurgery 1998;42:518–26.
   PubMed Web of Science ®Google Scholar
• Floeth FW, Sabel M, Ewelt C, et al. Comparison of (18)F-FET PET and 5-ALA fluorescence in cerebral gliomas. Eur J Nucl Med Mol Imaging 2011;38:731–41.
   PubMed Web of Science ®Google Scholar
• Hefti M, von Campe G, Moschopulos M, et al. 5-aminolevulinic acid induced protoporphyrin IX fluorescence in high-grade glioma surgery: a one-year experience at a single institutuion. Swiss Med Wkly 2008;138:180–5.
   PubMed Web of Science ®Google Scholar
• Ishihara R, Katayama Y, Watanabe T, et al. Quantitative spectroscopic analysis of 5-aminolevulinic acid-induced protoporphyrin IX fluorescence intensity in diffusely infiltrating astrocytomas. Neurol Med Chir (Tokyo) 2007;47:53–7.
   PubMed Web of Science ®Google Scholar
• Heyerdahl H, Wang I, Liu DL, et al. Pharmacokinetic studies on 5-aminolevulinic acid-induced protoporphyrin IX accumulation in tumours and normal tissues. Cancer Lett 1997;112:225–31.
   PubMed Web of Science ®Google Scholar
• Roberts DW, Valdés PA, Harris BT, et al. Glioblastoma multiforme treatment with clinical trials for surgical resection (aminolevulinic acid). Neurosurg Clin N Am 2012;23:371–7.
   PubMed Web of Science ®Google Scholar
• Shen SC, Lee WR, Fang YP, Hu CH, Fang JY. In vitro percutaneous absorption and in vivo protoporphyrin IX accumulation in skin and tumors after topical 5-aminolevulinic acid application with enhancement using an erbium: YAG laser. J Pharm Sci 2006;95:929–38.
   PubMed Web of Science ®Google Scholar